Neutralizing IL-23 and Its Targets May Improve Ankylosing Spondylitis Lara C. Pullen, PhD | August 30, 2012Researchers have identified a unique population of entheseal resident cells that can be activated by interleukin 23 (IL-23). This finding may be key to understanding how dysregulation of IL-23 results in precise inflammation of the entheses.